Volume 23, Number 10—October 2017
Research
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
Table 3
Demographic and clinical data for patients with PID whose fecal samples tested positive for nonpolio enteroviruses, Wadia Children’s Hospital, Mumbai, India, September 2014–April 2017*
Serial no. | Age, mo/ sex | PID type | Months from last OPV† | IVIG therapy | BMT | Results by collection day |
---|---|---|---|---|---|---|
1 | 114/F | IgG subclass deficiency | 60 | Yes | ND | D1, neg; D62, EV75; D214,neg; D250, neg; D419, neg; D476, neg; D685, neg |
2 | 42/M | Hyper-IgE syndrome | 24 | No | ND | D1, E13; lost to follow-up |
3 | 18/M | BENTA disease | NA | No | ND | D1, E5; D185, neg; D273, neg |
4 | 30/M | CGD | NA | No | ND | D1, E14; D10, died |
5 | 54/M | XLA | 1 | Yes | ND | D1, EV76; D107, neg; D136, neg; D260, neg |
*BENTA, B cell expansion with NF-κB and T cell anergy; BMT, bone marrow transplant; CGD, chronic granulomatous disease; D, day of collection following first collection; E5, echovirus 5; E13, echovirus 13; E14, echovirus 14; EV75, enterovirus 75; EV76, enterovirus 76; IVIG, intravenous immunoglobulin; NA, not available; ND, not done; neg, negative; OPV, oral polio vaccine; PID, primary immunodeficiency disease; XLA, X-linked agammaglobulinemia.
†Time from last OPV to first fecal sample collection.